modzatinib
What stands out
- Kinase inhibitor
Derived from WHO name stem · This is a summary of public records for informational purposes only. It is not medical advice.
History
Earliest recorded event: Aug 19, 2024. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.
- Mar 31, 2025Phase 2 trial completedStudy of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis ClinicalTrials.gov NCT06585202
- Mar 13, 2025Phase 2 main data collectedStudy of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis ClinicalTrials.gov NCT06585202
- Aug 19, 2024Phase 2 trial startedStudy of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis ClinicalTrials.gov NCT06585202
Sources
- Trials